JAMA Ophthalmology

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JANUARY 7, 2021

Media advisory: The full article is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaophthalmology/fullarticle/10.1001/jamaophthalmol.2020.6073?guestAccessKey=57d89ee8-3fb5-4fc6-8eb1-498769b5540b&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=010721

What The Study Did: To adapt to broader public health initiatives around COVID-19, researchers developed a drive-through intraocular pressure (IOP) screening clinic to minimize COVID-19 exposure for patients and clinicians by measuring eye pressure in the unconventional setting of a clinic parking lot.

Authors: Miel Sundararajan, M.D., of the University of California, San Francisco, is the corresponding author.

(doi:10.1001/jamaophthalmol.2020.6073)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.